Alnylam Pharmaceuticals
ALNY
#683
Rank
โ‚น3.513 T
Marketcap
โ‚น26,316
Share price
2.03%
Change (1 day)
-4.69%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company